Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) announces it has completed the acquisition of RLS (USA) Inc. (RLS; RLS Radiopharmacies), America’s only Joint Commission-accredited radiopharmacy network distributing PET, SPECT and therapeutic radiopharmaceuticals. The acquisition immediately enhances Telix’s presence in the United States (U.S.), with a network of over 30 radiopharmacies dispensing radiopharmaceuticals manufactured by Telix and other companies, while bringing a team of highly-skilled and multi-disciplinary radiopharmaceutical professionals into the Company.
Read the full article: Telix Completes Acquisition of RLS (USA) Inc. //
Source: https://www.globenewswire.com/news-release/2025/01/27/3016008/0/en/Telix-Completes-Acquisition-of-RLS-USA-Inc.html